Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cvxl-0107 (1 trial)
levodopa (larodopa) (1 trial)
Parkinson Disease (Phase 2)
Trials (1 total)
Trial APIs (2 total)